Cargando…
Polymorphism of C3 complement in association with myocardial infarction in a sample of central Tunisia
BACKGROUND: Myocardial infarction (MI) is a major clinical problem because of its large contribution to mortality. The genetic bases of this disease have been widely studied in recent years to find a clear association with some genetic markers that increase the risk of its occurrence. In the present...
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3931526/ https://www.ncbi.nlm.nih.gov/pubmed/23764154 http://dx.doi.org/10.1186/1746-1596-8-93 |
_version_ | 1782304671419858944 |
---|---|
author | Leban, Nadia Jraba, Karim Chalghoum, Abdelkader Hassine, Selma Elhayek, Donia Denden, Sabri Lakhdhar, Ramzi Maatoug, Faouzi Gamra, Habib Braham, Hammadi Chibani, Jemni Ben Khelil, Amel Haj |
author_facet | Leban, Nadia Jraba, Karim Chalghoum, Abdelkader Hassine, Selma Elhayek, Donia Denden, Sabri Lakhdhar, Ramzi Maatoug, Faouzi Gamra, Habib Braham, Hammadi Chibani, Jemni Ben Khelil, Amel Haj |
author_sort | Leban, Nadia |
collection | PubMed |
description | BACKGROUND: Myocardial infarction (MI) is a major clinical problem because of its large contribution to mortality. The genetic bases of this disease have been widely studied in recent years to find a clear association with some genetic markers that increase the risk of its occurrence. In the present investigation, the correlation between MI and the C3 complement polymorphism was analyzed using a case–control study. METHODS: Our study ported on one hundred seventy survived myocardial infarction patients and ninety five healthy controls. The C3 allele identification was investigated using the amplification refractory mutation system PCR to determine the C3*S and the C3*F alleles of the C3 polymorphism. RESULTS: Frequencies of C3*S and C3*F in patients are 0.59 and 0.41 respectively. Fisher test results showed a significant increase of C3*F allele in the sample of patients (0.41; odds ratio: 2.616; C.I [1.738-3.938]) compared to controls (0.21; odds ratio: 0.382; 95% CI [0.254-0.575]), p = 2.742 × 10(-6). CONCLUSION: A strong positive correlation was found between C3 polymorphism and MI estimating that the risk of myocardial infarction is significantly increased among patients with C3*F allele of this polymorphism. VIRTUAL SLIDES: The virtual slide(s) for this article can be found here: http://www.diagnosticpathology.diagnomx.eu/vs/1190484203893646 |
format | Online Article Text |
id | pubmed-3931526 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2013 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-39315262014-02-22 Polymorphism of C3 complement in association with myocardial infarction in a sample of central Tunisia Leban, Nadia Jraba, Karim Chalghoum, Abdelkader Hassine, Selma Elhayek, Donia Denden, Sabri Lakhdhar, Ramzi Maatoug, Faouzi Gamra, Habib Braham, Hammadi Chibani, Jemni Ben Khelil, Amel Haj Diagn Pathol Research BACKGROUND: Myocardial infarction (MI) is a major clinical problem because of its large contribution to mortality. The genetic bases of this disease have been widely studied in recent years to find a clear association with some genetic markers that increase the risk of its occurrence. In the present investigation, the correlation between MI and the C3 complement polymorphism was analyzed using a case–control study. METHODS: Our study ported on one hundred seventy survived myocardial infarction patients and ninety five healthy controls. The C3 allele identification was investigated using the amplification refractory mutation system PCR to determine the C3*S and the C3*F alleles of the C3 polymorphism. RESULTS: Frequencies of C3*S and C3*F in patients are 0.59 and 0.41 respectively. Fisher test results showed a significant increase of C3*F allele in the sample of patients (0.41; odds ratio: 2.616; C.I [1.738-3.938]) compared to controls (0.21; odds ratio: 0.382; 95% CI [0.254-0.575]), p = 2.742 × 10(-6). CONCLUSION: A strong positive correlation was found between C3 polymorphism and MI estimating that the risk of myocardial infarction is significantly increased among patients with C3*F allele of this polymorphism. VIRTUAL SLIDES: The virtual slide(s) for this article can be found here: http://www.diagnosticpathology.diagnomx.eu/vs/1190484203893646 BioMed Central 2013-06-13 /pmc/articles/PMC3931526/ /pubmed/23764154 http://dx.doi.org/10.1186/1746-1596-8-93 Text en Copyright © 2013 Leban et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Research Leban, Nadia Jraba, Karim Chalghoum, Abdelkader Hassine, Selma Elhayek, Donia Denden, Sabri Lakhdhar, Ramzi Maatoug, Faouzi Gamra, Habib Braham, Hammadi Chibani, Jemni Ben Khelil, Amel Haj Polymorphism of C3 complement in association with myocardial infarction in a sample of central Tunisia |
title | Polymorphism of C3 complement in association with myocardial infarction in a sample of central Tunisia |
title_full | Polymorphism of C3 complement in association with myocardial infarction in a sample of central Tunisia |
title_fullStr | Polymorphism of C3 complement in association with myocardial infarction in a sample of central Tunisia |
title_full_unstemmed | Polymorphism of C3 complement in association with myocardial infarction in a sample of central Tunisia |
title_short | Polymorphism of C3 complement in association with myocardial infarction in a sample of central Tunisia |
title_sort | polymorphism of c3 complement in association with myocardial infarction in a sample of central tunisia |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3931526/ https://www.ncbi.nlm.nih.gov/pubmed/23764154 http://dx.doi.org/10.1186/1746-1596-8-93 |
work_keys_str_mv | AT lebannadia polymorphismofc3complementinassociationwithmyocardialinfarctioninasampleofcentraltunisia AT jrabakarim polymorphismofc3complementinassociationwithmyocardialinfarctioninasampleofcentraltunisia AT chalghoumabdelkader polymorphismofc3complementinassociationwithmyocardialinfarctioninasampleofcentraltunisia AT hassineselma polymorphismofc3complementinassociationwithmyocardialinfarctioninasampleofcentraltunisia AT elhayekdonia polymorphismofc3complementinassociationwithmyocardialinfarctioninasampleofcentraltunisia AT dendensabri polymorphismofc3complementinassociationwithmyocardialinfarctioninasampleofcentraltunisia AT lakhdharramzi polymorphismofc3complementinassociationwithmyocardialinfarctioninasampleofcentraltunisia AT maatougfaouzi polymorphismofc3complementinassociationwithmyocardialinfarctioninasampleofcentraltunisia AT gamrahabib polymorphismofc3complementinassociationwithmyocardialinfarctioninasampleofcentraltunisia AT brahamhammadi polymorphismofc3complementinassociationwithmyocardialinfarctioninasampleofcentraltunisia AT chibanijemniben polymorphismofc3complementinassociationwithmyocardialinfarctioninasampleofcentraltunisia AT khelilamelhaj polymorphismofc3complementinassociationwithmyocardialinfarctioninasampleofcentraltunisia |